Ashish K. Khanna, MD, FCCP, FASA,FCCM

Anesthesiologist & Intensivist, Associate Professor of Anesthesiology
Wake Forest Baptist Medical Center
Winston Salem, North Carolina

Ashish K.Khanna, MD, FCCP, FCCM, is a staff intensivist & anesthesiologist, associate professor of anesthesiology and vice-chair for research with the department of anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine, Winston-Salem, NC. He is a member of the Wake Center for Biomedical Informatics, the Center for Healthcare Innovation, the Wake Forest Hypertension and Vascular Research Cardiovascular Sciences Center and the Critical Illness, Injury and Recovery Research Center (CIIRRC).

Dr.Khanna is a past chair of the Society of Critical Care Medicine’s (SCCM) In-Training Section and the SCCM Postgraduate and Fellowship Education Committee. He is a program co-chair for SCCM 2023, and part of the SCCM Discovery Research Network Steering Committee ( term until 2022), chair-elect of the SCCM Research Section, and the SCCM Anesthesiology Section Steering Committee. Dr.Khanna is also vice-chair for the American Society of Anesthesiologists (ASA) committee on critical care medicine.

His research interests include, prediction of post-operative respiratory and cardiac events on the regular nursing floor, outcomes of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. From 2015-2017 Dr.Khanna was the lead investigator for the Angiotensin II in High Output Shock (ATHOS-3) trial, that was subsequently published in the NEJM in the summer of 2017. Other notable work includes the EPIC III trial that examined infections in the ICU was published in the JAMA in March 2020. He has more than 100 peer reviewed papers, and in addition two dozen book chapters, editorials, invited non-peer reviewed articles, and online educational videos to his credit and has been invited to talk about his work at prestigious national and international forums.

Disclosure information not submitted.

Presentation(s):

• A Pandemic Within an Epidemic: Evaluation of COVID-19 in the Obese Population

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Angiotensin II for Distributive Shock in Patients With Durable Left Ventricular Assist Devices

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Early- Versus Late-Onset Septic Shock: Does It Really Matter?

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Intra-Abdominal Hypertension Detected by Continuous Monitoring Is Common and Persistent in the CVICU

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Machine Learning-Based Early Mortality Prediction at the Time of ICU Admission

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Norepinephrine Equivalent Dose Is Strongly Associated With In-Hospital Mortality in Septic Shock

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Synthetic Angiotensin II Use During Temporary Mechanical Circulatory Support

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST

• Zinc use is associated with improved outcomes in COVID-19: Results from the CRUSH-COVID registry

  Monday, April 18, 2022
  7:00 AM – 8:00 AM US CST